The Vanguard Group 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-29 2:41 pm Sale | 2025-06-30 | 13G | Sutro Biopharma, Inc. STRO | The Vanguard Group | 411,525 4.870% | -7,982 (-1.90%) | Filing |
| 2024-11-12 5:46 pm Unchanged | 2024-09-30 | 13G | Sutro Biopharma, Inc. STRO | The Vanguard Group | 419,507 5.110% | 0 (Unchanged) | Filing |
| 2024-11-04 2:09 pm Purchase | 2024-09-30 | 13G | Sutro Biopharma, Inc. STRO | The Vanguard Group | 419,507 5.110% | 419,507 (New Position) | Filing |